Relationship between fractures, QoL, morbidity, and mortality
What is the relation between fractures and quality of life, morbidity, and mortality?
What is the relation between fractures and quality of life, morbidity, and mortality?
When should we suspect macrophage activation syndrome in patients with adult-onset Still disease?
Which classes of drugs should be avoided in elderly patients because of increased risk of fractures? Does this include selective serotonin reuptake inhibitors (SSRIs) commonly used to treat depression?
What is new in the diagnosis and treatment of systemic vasculitis?
Can bisphosphonates be used in patients with moderate renal impairment? What are the potential adverse effects of these drugs? Is denosumab a better choice in such patients?
What is new in the 2014 International Criteria for Behçet Disease?
What is the effectiveness of pharmacological treatment of osteoporosis in elderly patients? Do bisphosphonates reduce the risk of fractures if started late in life, eg, in patients aged >80 years?
Is plasmapheresis an effective treatment in rheumatologic emergencies?
Secondary amyloidosis is a potentially fatal complication of chronic inflammatory diseases. When should it be suspected?